Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2124934 | European Journal of Cancer | 2006 | 7 Pages |
Abstract
In total, 33 patients had a documented relapse 5 years or more after diagnosis. Half of the patients had good response (⩾90% necrosis) to pre-operative chemotherapy and the other half a poor response (<90% necrosis) and late relapses seemed to be more frequently proportionately in those who had a good initial response to chemotherapy. The occurrence of late relapse did not appear to be associated with age or gender. Although not statistically significant, there was a trend for patients with a chondroblastic subtype of osteosarcoma, or a location in the tibia or fibula, to have a higher risk for late relapse.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
E.I. Hauben, S. Bielack, R. Grimer, G. Jundt, P. Reichardt, M. Sydes, A.H.M. Taminiau, P.C.W. Hogendoorn,